H.R. 6396: Kid Providing Resources for Optimal Outcomes against Fatalities Act of 2025

This bill, known as the Kid Providing Resources for Optimal Outcomes against Fatalities Act of 2025 or the Kid PROOF Act of 2025, aims to enhance support and funding for preventing suicide and overdose among children, adolescents, and young adults. It proposes amendments to the existing SUPPORT for Patients and Communities Act to broaden the scope of services provided to this age group.

Key Provisions

• Inclusion of Suicide Prevention: The bill expands the scope of treatment services to include intervention for suicide prevention, in addition to substance abuse treatment.
• Eligibility for Grants: It specifies that certain health care agencies, facilities, and providers, including children's hospitals and mental health specialists, can receive grants to support these initiatives.
• Parent and Guardian Involvement: The bill emphasizes the importance of involving parents and legal guardians by allowing eligible entities to provide counseling and supplies intended to prevent overdose and suicide, with the consent of parents or guardians of minors.
• Funding Schedule: The bill updates the authorizing period for grants, extending it through the fiscal years 2026 to 2030. It also ensures that at least $2 million will be allocated annually for grant awards meant to support prevention and treatment initiatives.

Grant Usage and Support

Under this proposed legislation, grants can be used for:

• Providing counseling to parents on how to prevent overdose and suicide.
• Supplying parents with tools and resources to mitigate the risk of lethal means associated with overdose and suicide.

Intended Impact

The intent of the bill is to address the growing concerns of mental health crises among youth by providing more resources and structured support. This includes a focus on both preventive measures and direct intervention for those who may be at risk of suicide or overdose.

Relevant Companies

• ABT - Abbott Laboratories: May be involved in developing and supplying mental health treatment products.
• PFE - Pfizer Inc.: As a pharmaceutical company, it may be affected by increased focus on mental health treatments and medications.
• UNH - UnitedHealth Group Incorporated: Being involved in healthcare services, this company may see changes in funding and service provision related to mental health initiatives.